Clinical Trials

The primary purpose of this study is to analyze maxillary transverse dimensions in children who have completed polysomnography (PSG), using McNamara’s Criteria and Andrew’s Six Elements.

The primary aim in Phase I of the study is to evaluate whether the proposed sensing technology was demonstrated to be exceptionally effective. In Phase II of the study, the following aims are proposed to mature the prototype hardware into a production ready system, to finalize processing software and develop interfaces for end users / clinicians, and to validate system performance against current state-of-the-art system in a human subject study.

The purpose of this study is to verify that a relatively inexpensive, readily available activity monitor can be used in sleep research.  Specifically, the interest is on children and adolescents as they will be the focus of future research.

The purpose of this study is to demonstrate proof-of-concept feasibility for Mayo OMNI physiologic monitor correlation with sleep-wake measures obtained from the current gold-standards of actigraphy and polysomnography. 

The purpose of this study is to determine whether FT218 is safe and effective for the treatment of excessive daytime sleepiness and cataplexy in subjects with narcolepsy.

The purpose of this study is to eEvaluate an under-mattress sleep monitor compared to a peripheral arterial tonometry home sleep apnea test device in the diagnosis of obstructive sleep apnea.